Reducing Adult Inpatients Anxiety With Virtual Reality Meditation

Anxiety Clinical Trial

Official title:

Reducing Adult Inpatients Anxiety With Virtual Reality Meditation: A Prospective, Randomized Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06234254
• Other study ID #: 73841
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 1, 2025
• Est. completion date: May 31, 2026

Study information

• Verified date: April 2024
• Source: Stanford University
• Contact: Thomas Caruso
• Phone: 650-723-5728
• Email: tjcaruso[@]stanford.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to evaluate if non-invasive, distracting devices (virtual reality) can decrease anxiety and improve affect and satisfaction in adult, hospitalized patients.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 200
• Est. completion date: May 31, 2026
• Est. primary completion date: May 31, 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• between age 18-99
• hospitalized at Stanford Health Care
• english-speaking

Exclusion Criteria:

• significant cognitive impairment or inability to consent
• current nausea
• visual problems or currently using corrective glasses that are incompatible with the virtual reality headset
• a history of severe motion sickness
• a history of seizures cause by flashing light
• clinically unstable or require immediate/urgent intervention

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Virtual Reality

Intervention

Behavioral:
• Virtual Reality headset with calming scenery
Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes

Locations

Country	Name	City	State
United States	Stanford Health Care (SHC)	Palo Alto	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hospital Anxiety and Depression Scale (HADS)	Hospital Anxiety and Depression Scale (HADS) questionnaire. The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.	Before and Immediate after intervention